long-awaited landmark hypertension study will shake things up

The surprising results from the long-awaited landmark hypertension study will shake things up.

Canadian guidelines currently recommend a diuretic, ACE inhibitor, calcium channel blocker, or beta-blocker for initial treatment of high blood pressure.

Now the huge ALLHAT study suggests that a diuretic is often a better first choice than the others.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote